Levosimendan is an inotropic agent that has been shown in small studies to prevent or treat the low cardiac output syndrome after cardiac surgery. In a multicenter, randomized, placebo-controlled, ...
(MENAFN- GlobeNewsWire - Nasdaq) Increasing Demand for ECMO Systems, Portable Devices, and Pediatric Cardiac Support, Along with Expanding Hospital Infrastructure and Smart Monitoring Innovations, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results